Showing results (181-190 of 201) with videos related to
Sort By:
Pageof 21
Blood|April 4, 2013
The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombiMehran Ghasemzadeh, Zane S Kaplan, Imala Alwis, et al.Plos Pathogens|October 25, 2021
CD4+ T cell immunity to Salmonella is transient in the circulationNewton G Peres, Nancy Wang, Paul Whitney, et al.Clinical & Translational Immunology|May 27, 2024
Engineered CAR-T cells targeting the non-functional P2X purinoceptor 7 (P2X7) receptor as a novel treatment for ovarian cancerVeronika Bandara, Victoria M Niktaras, Vasiliki J Willett, et al.Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
Scavenging of soluble and immobilized CCL21 by ACKR4 regulates peripheral dendritic cell emigrationCameron R Bastow, Mark D Bunting, Ervin E Kara, et al.Nature Medicine|April 17, 2007
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitmentJürgen Bernhagen, Regina Krohn, Hongqi Lue, et al.Nature Communications|June 6, 2017
IL-17-producing γδ T cells switch migratory patterns between resting and activated statesDuncan R McKenzie, Ervin E Kara, Cameron R Bastow, et al.Blood|April 24, 2007
IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tractAngela C Burman, Tatjana Banovic, Rachel D Kuns, et al.Breast Cancer Research : BCR|April 19, 2015
Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapyKimberly A Snyder, Michael R Hughes, Bradley Hedberg, et al.The Journal of Experimental Medicine|April 15, 2020
ACKR4 restrains antitumor immunity by regulating CCL21Carly E Whyte, Maleika Osman, Ervin E Kara, et al.Nature Communications|October 30, 2015
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cellsErvin E Kara, Duncan R McKenzie, Cameron R Bastow, et al.Pageof 21